{
  "id": "268281433e099eb6",
  "title": "Pfizer BRAFTOVI\u00ae Regimen with Additional Chemotherapy Backbone Increased Response Rates for Certain Patients with Metastatic Colorectal Cancer",
  "description": "20260110T211500Z",
  "content": "",
  "source": "pharmiweb.com",
  "source_url": "https://www.pharmiweb.com/press-release/2026-01-10/pfizer-s-braftovi-regimen-with-additional-chemotherapy-backbone-increased-response-rates-for-certai",
  "published_at": "20260110T211500Z",
  "fetched_at": "2026-01-11T00:26:01.619835+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "ai"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://www.pharmiweb.com/press-release/2026-01-10/pfizer-s-braftovi-regimen-with-additional-chemotherapy-backbone-increased-response-rates-for-certai",
    "url_mobile": "",
    "title": "Pfizer BRAFTOVI\u00ae Regimen with Additional Chemotherapy Backbone Increased Response Rates for Certain Patients with Metastatic Colorectal Cancer",
    "seendate": "20260110T211500Z",
    "socialimage": "https://cdn.pharmiweb.com/media/1024/1200x448-pwjobs.png",
    "domain": "pharmiweb.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}